Where does Metgen OY rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Metgen OY ranks #18,895 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Metgen OY hold?

Metgen OY holds 15 US utility patents granted between 2017 and 2025, spanning 15 technology areas.

What is Metgen OY's Innovation Score?

Metgen OY has an Innovation Score of 34.1 out of 100 (47th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Metgen OY focus on?

Metgen OY's top technology area is C12Y (Enzymes) with 13 patents, ranking #203 of 1,675 assignees active in that subclass. Grants appear in 15 CPC subclasses total.

Is Metgen OY's patent grant rate increasing or decreasing?

Metgen OY's recent grant velocity is +60% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Metgen OY's patents?

Metgen OY's patents average 15.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Metgen OY patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Metgen OY

USPTO PatentsView assignee record - 15 granted patents across 15 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Y (Enzymes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Metgen ranks #18,895 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 15 technology areas.

#18,895
of 49,997 US assignees by volume: 47th percentile
by Innovation Score (34.1/100): 15.3
avg claims per patent: +60%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18895 · Foreign Corporation #18,895 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 15 grants
MID-PACK #18,895/49,997
PHOTO-FINISH Medasense Biometrics
CPC-FOCUS C12Y · 15 areas
INNOV-THIN 34.1/100
CLAIMS-RICH 15.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +60% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Medasense Biometrics Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Metgen’s 34.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (28%) Velocity 1.7 pts (5%) Breadth 13.7 pts (40%) Claim depth 9.2 pts (27%)

Qualcomm Incorporated · highest

85
Metgen OY · this assignee

34
3D Lighting… · lowest

7

What this shows Metgen's Innovation Score is 34.1/100 (47th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Metgen?

Each dot is one of Metgen’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Metgen’s own 15.3 claims/patent is ABOVE the 11.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Metgen vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Metgen's grants concentrate

Metgen OY is a focused PatentsView assignee: 15 CPC subclasses with 86.7% of grants classified under C12Y (Enzymes). Peak complete grant year is 2020 (5 grants) versus a trough of 1 in 2017. By volume, Metgen sits between Medasense Biometrics Ltd. and Mobeus Industries, Inc..

Metgen's three-year grant acceleration

Metgen OY shows 2 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Medasense Biometr…

15
Megmilk Snow Brand

15
Merck Kgaa

15
Mertek Industries

15
Michael HÖRAUF Ma…

15
Microbial Discove…

15
Midea America

15
Mobeus Industries

15
Metgen OY ◀

15

What this shows Metgen holds 15 patents at rank #18,877, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Metgen

By rank, the assignees closest to #18,877 in granted patent volume.

Leaders in C12Y (Enzymes)

Other assignees with the most granted patents in Metgen's primary technology class.

Metgen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 47th percentile higher than 47% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Metgen OY patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	6.7%
2018	2	13.3%
2019	2	13.3%
2020	5	33.3%
2021	1	6.7%
2022	2	13.3%
2025partial year	2	13.3%

Which technologies does Metgen OY patent most?

C12Y - Enzymes 13

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 11

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 9

D21C - Production OF Cellulose BY Removing Non-cellulose Substances From Cellulose-containing MATERIALS; Regeneration OF Pulping LIQUORS; Apparatus Therefor 3

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 2

C07K - Peptides 2

D21H - Pulp COMPOSITIONS; Preparation Thereof NOT Covered BY Subclasses D21c OR D21D; Impregnating OR Coating OF PAPER; Treatment OF Finished Paper NOT Covered BY Class B31 OR Subclass D21G; Paper NOT Otherwise Provided FOR 2

C11D - Detergent COMPOSITIONS; USE OF Single Substances AS DETERGENTS; Soap OR SOAP-MAKING; Resin SOAPS; Recovery OF Glycerol 1

C08L - Compositions OF Macromolecular Compounds 1

C08H - Derivatives OF Natural Macromolecular Compounds 1

C07G - Compounds OF Unknown Constitution 1

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 1

C13K - Saccharides Obtained From Natural Sources OR BY Hydrolysis OF Naturally Occurring Disaccharides, Oligosaccharides OR Polysaccharides 1

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 1

D21B - Fibrous RAW Materials OR Their Mechanical Treatment 1

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Metgen OY's patent record in context - here's where to go next.

Metgen OY's lead technology class is C12Y (Enzymes), 86.7% of its portfolio - see every assignee active in that class. Explore C12Y
Ranked #18,895 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Metgen OY against Medasense Biometrics Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.